Henry T. Lynch, M.D., Kelly Ferrara, M.S., Bart Barlogie, M.D., Ph.D., Elizabeth A. Coleman, Ph.D., Jane F. Lynch, B.S.N., Dennis Weisenburger, M.D., Warren Sanger, Ph.D., Patrice Watson, Ph.D., Henry Nipper, Ph.D., Vinetta Witt, Ph.D., and Stephan Thomé, M.D.
We describe a family with five cases of multiple myeloma, threecases of monoclonal gammopathy of undetermined significance(MGUS), and five cases of prostate cancer in two generations.The putative progenitor had progeny with two female partners.The progeny had prostate cancer, multiple myeloma, and MGUS.
Source Information
From Creighton University School of Medicine (H.T.L., K.F., J.F.L., P.W., S.T.); Nebraska Medical Center (D.W., W.S.); and Creighton University Medical Center (H.N.) — all in Omaha; the University of Arkansas for Medical Sciences, Little Rock (B.B., E.A.C.); and Newberry College, Newberry, SC (V.W.).
Familial Myeloma
Camp N. J., Werner T. L., Cannon-Albright L. A., Lynch H. T., Thomé S.
Extract |
Full Text |
PDF
N Engl J Med 2008;
359:1734-1735, Oct 16, 2008.
Correspondence
This article has been cited by other articles:
Kristinsson, S. Y., Goldin, L. R., Bjorkholm, M., Koshiol, J., Turesson, I., Landgren, O.
(2009). Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies. haematol
94: 1581-1589
[Abstract][Full Text]
Kristinsson, S. Y., Goldin, L. R., Bjorkholm, M., Turesson, I., Landgren, O.
(2009). Risk of solid tumors and myeloid hematological malignancies among first-degree relatives of patients with monoclonal gammopathy of undetermined significance. haematol
94: 1179-1181
[Full Text]
Lynch, H. T., Thome, S. D.
(2009). Familial multiple myeloma. Blood
114: 749-750
[Full Text]
Vachon, C. M., Kyle, R. A., Therneau, T. M., Foreman, B. J., Larson, D. R., Colby, C. L., Phelps, T. K., Dispenzieri, A., Kumar, S. K., Katzmann, J. A., Rajkumar, S. V.
(2009). Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance. Blood
114: 785-790
[Abstract][Full Text]
Landgren, O., Kristinsson, S. Y., Goldin, L. R., Caporaso, N. E., Blimark, C., Mellqvist, U.-H., Wahlin, A., Bjorkholm, M., Turesson, I.
(2009). Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden. Blood
114: 791-795
[Abstract][Full Text]
Iwanaga, M., Tagawa, M., Tsukasaki, K., Matsuo, T., Yokota, K.-i., Miyazaki, Y., Fukushima, T., Hata, T., Imaizumi, Y., Imanishi, D., Taguchi, J., Momita, S., Kamihira, S., Tomonaga, M.
(2009). Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors. Blood
113: 1639-1650
[Abstract][Full Text]
Camp, N. J., Werner, T. L., Cannon-Albright, L. A., Lynch, H. T., Thome, S.
(2008). Familial Myeloma. NEJM
359: 1734-1735
[Full Text]
Previous
